Clinical Trials Browser

Phase 2 × Interventional × Lower Urinary Tract Symptoms × Clear all

NCT00866554 2023-06-02

Efficacy and Toxicity of Bicalutamide and Dutasteride vs. Standard Care for Prostate Cytoreduction for Brachytherapy

Phase 2 Completed

Erectile Dysfunction, Prostatic Neoplasms, Lower Urinary Tract Symptoms

NCT03549650 2022-03-04

Prevention and Management of Intravesical BCG-related Lower Urinary Tract Symptoms

Phase 2 Terminated

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Lower Urinary Tract Symptoms

NCT01678313 2014-07-15

Cyclooxygenase-2 (COX-2) Inhibitor Reduces Serum Prostatic Specific Antigen (PSA) Levels

Phase 2 Completed

140 enrolled 10 charts

Prostatic Hyperplasia, Lower Urinary Tract Symptoms

NCT00410514 2014-04-04

A Study of Mirabegron (YM178) in Men With Lower Urinary Tract Symptoms (LUTS) and Bladder Outlet Obstruction (BOO)

Phase 2 Completed

200 enrolled 24 charts

EndocrineGenitourinary

Urinary Bladder Neck Obstruction, Multiple Endocrine Neoplasia Type 1, Lower Urinary Tract Symptoms

NCT00681148 2013-11-21

Botulinum Toxin Injection With Prostate Brachytherapy

Phase 2 Withdrawn

Prostatic Neoplasms, Lower Urinary Tract Symptoms